Cargando…
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
SIMPLE SUMMARY: Cancer deaths are predominantly due to metastases rather than the primary tumors, and thus there is an urgent need for the discovery of more effective drug therapies for metastatic cancer. Recent genomics, transcriptomics, and proteomics studies have identified tyrosine kinase 2 (TYK...
Autores principales: | Borcherding, Dana C., He, Kevin, Amin, Neha V., Hirbe, Angela C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393599/ https://www.ncbi.nlm.nih.gov/pubmed/34439323 http://dx.doi.org/10.3390/cancers13164171 |
Ejemplares similares
-
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
por: Borcherding, Dana C., et al.
Publicado: (2023) -
TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death
por: Qin, Wenjing, et al.
Publicado: (2019) -
TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020) -
TYK2: An Upstream Kinase of STATs in Cancer
por: Wöss, Katharina, et al.
Publicado: (2019) -
TYK2 in Immune Responses and Treatment of Psoriasis
por: Shang, Lin, et al.
Publicado: (2022)